Palatine Tonsils Primary Presentation of Blastoid Variant of Mantle Cell Lymphoma: Case Report

Head Neck Pathol. 2021 Jun;15(2):588-592. doi: 10.1007/s12105-020-01238-9. Epub 2020 Oct 22.

Abstract

Head and neck lymphomas can present with a wide range of symptoms. Timely and accurate diagnosis is often challenging. The blastoid variant of mantle cell lymphoma (MCL) accounts for less than one-third of all MCL cases. Isolated primary presentation on the palatine tonsils is rare, and prognosis and outcome are seemingly unfavorable. An 81-year-old man presented with persistent odynophagia, dysphagia, and obstructive hypertrophic palatine tonsils with purulent exudate. The signs and symptoms were non-responsive to antibiotic therapy, and the tonsils were biopsied. The cellular morphology, immunophenotype, and genotype supported a diagnosis of the blastoid variant of MCL. After staging, the patient underwent chemotherapy with Rituximab-Bendamustine (R-Benda). The patient is in clinical remission more than two years after therapy. We report an exceedingly rare case of blastoid MCL that is prone to be misdiagnosed as tonsillitis. We review the literature and discuss treatment options of this uncommon malignancy.

Keywords: Blastoid variant; Head and neck lymphoma; Mantle cell lymphoma; Palatine tonsil lymphoma; Waldeyer’s ring.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bendamustine Hydrochloride / therapeutic use
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy
  • Lymphoma, Mantle-Cell / pathology*
  • Male
  • Palatine Tonsil / pathology*
  • Rituximab / therapeutic use
  • Tonsillar Neoplasms / drug therapy
  • Tonsillar Neoplasms / pathology*

Substances

  • Rituximab
  • Bendamustine Hydrochloride